Clinical Trial Update: Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer

View source ↗

Summary

A compassionate-use trial of Casodex 150-mg for prostate cancer is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Casodex 150-mg (bicalutamide)

Snippet

Sponsor: AstraZeneca | Conditions: Adenocarcinoma of the Prostate | Status: NO_LONGER_AVAILABLE